| case report | Q2782326 |
| scholarly article | Q13442814 |
| P50 | author | Nahid Bhadelia | Q59820429 |
| P2093 | author name string | E Yoko Furuya | |
| George R Thompson | |||
| Asma Lat | |||
| Benjamin Miko | |||
| P2860 | cites work | Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease | Q28251330 |
| Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America | Q28263689 | ||
| Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. | Q30381573 | ||
| Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. | Q30382272 | ||
| Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. | Q30385421 | ||
| Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients. | Q30386485 | ||
| Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome | Q34515095 | ||
| Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. | Q35532895 | ||
| Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease | Q40844329 | ||
| Invasive Pulmonary Aspergillosis Associated With Influenza | Q41022812 | ||
| Bone marrow B cell apoptosis during in vivo influenza virus infection requires TNF-alpha and lymphotoxin-alpha | Q44223891 | ||
| Influenza virus infection induces functional alterations in peripheral blood lymphocytes | Q45848185 | ||
| Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient | Q69867171 | ||
| Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
| P433 | issue | 6 | |
| P921 | main subject | aspergillosis | Q259626 |
| pandemic | Q12184 | ||
| invasive aspergillosis | Q3625278 | ||
| P304 | page(s) | 971-973 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Emerging Infectious Diseases | Q5235761 |
| P1476 | title | Invasive aspergillosis after pandemic (H1N1) 2009. | |
| P478 | volume | 16 |
| Q37192161 | A Case of Acute Cerebral Aspergillosis Complicating Influenza A/H1N1pdm 2009 |
| Q54967595 | Acute fulminant invasive pulmonary aspergillosis in an immunocompetent host: An autopsy case report. |
| Q30355446 | Adjunctive therapies and immunomodulating agents for severe influenza. |
| Q30429289 | Adjunctive therapies and immunomodulatory agents in the management of severe influenza |
| Q37943846 | Aspergillosis in the 'nonimmunocompromised' host |
| Q53458650 | Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis |
| Q30417557 | Cryptococccal meningoencephalitis after H1N1 influenza |
| Q57016763 | Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome |
| Q30459034 | Emerging novel and antimicrobial-resistant respiratory tract infections: new drug development and therapeutic options |
| Q30367762 | Fatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient. |
| Q42157738 | Flucytosine for treatment of Candida albicans in H1N1-positive patient |
| Q34894660 | How to approach and treat viral infections in ICU patients |
| Q30421504 | Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients |
| Q98165023 | Influenza challenging the diagnosis and management of pulmonary coccidioidomycosis |
| Q30400852 | Influenza-Associated Aspergillosis in Critically Ill Patients. |
| Q96138684 | Influenza-associated aspergillosis in critically-ill patients-a retrospective bicentric cohort study |
| Q37305560 | Invasive Aspergillosis Associated With Severe Influenza Infections |
| Q52600262 | Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts. |
| Q41857104 | Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient |
| Q49897827 | Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature |
| Q38303110 | Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature |
| Q43631437 | Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study |
| Q36252445 | Isolation of Aspergillus in three 2009 H1N1 influenza patients |
| Q30411724 | Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection |
| Q30456363 | Newer influenza antivirals, biotherapeutics and combinations |
| Q30410436 | Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. |
| Q37671496 | Post-influenza aspergillosis, do not underestimate influenza B. |
| Q34532546 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America |
| Q57214260 | TR34/L98H Mutation in CYP51A Gene in Aspergillus fumigatus Clinical Isolates During Posaconazole Prophylaxis: First Case in Korea |
| Q35277785 | The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease |
| Q47554935 | The role of adjuvant immunomodulatory agents for treatment of severe influenza |
| Q28488181 | Transcriptome and biochemical analysis reveals that suppression of GPI-anchor synthesis leads to autophagy and possible necroptosis in Aspergillus fumigatus |
Search more.